Navigation Links
AFTS Labs Partners With Physicians To Complement NY's Mandated I-STOP Tracking System For Pain Pill Prescriptions: A Recipe For A Safer Community
Date:7/1/2012

(PRWEB) July 01, 2012

The prescription drug abuse problem has skyrocketed in the past decade. According to the Center for Disease Control (CDC), over 20,000 Americans die each year of prescription drug abuse. Opioid pain relievers now account for more overdose deaths than cocaine and heroin combined.

The landmark deal that was announced by Governor Cuomo mandates real-time tracking when doctors write prescriptions for controlled substances and when pharmacists fill them. Prior to this deal, participation was not mandatory, however all physicians must participate in this new tracking system.

AFTS Labs is dedicated to combating this growing drug problem by educating physicians, staff, and community on better prescription drug safety protocols. “Now that physicians are being mandated to track the prescriptions of their pain patients, AFTS Labs is on a quest to help physicians and their practices combat prescription drug abuse. A large part of our business is given back in the form of educating physicians on teaching their staff and patients on safety protocols when it comes to medication monitoring”, said Dr. Richard Stripp, owner and chief toxicologist at AFTS Labs.

AFTS Labs is committed to helping physicians make informed decisions for improved patient care. In the face of current national trends, there are many clinical reasons for incorporating drug testing into routine pain practices:

  •     Provides the clinician with an objective test that documents prescription drug adherence, misuse and/or illicit drug usage.
  •     Identifies drugs that have the potential to cause adverse reactions.
  •     Aids in the diagnosis or treatment of disease or addiction.
  •     Confirms compliance with the agreed upon treatment plan and makes the patient aware that drug testing is an essential part of the treatment plan.
  •     Identifies intentional dilution, adulteration, substitution or tampering of the specimen.
  •     Justifies the continuation of chronic opioid therapy in patients who adhere to the treatment plan and have acceptable drug tests.
  •     Provides rationale to change the treatment plan in patients with unacceptable drug tests and supports referral to addiction specialists.
  •     Identifies the use of medications from other sources that can complicate the treatment plan.
  •     Serves as a resource when doctors are acting as advocates for the patients in family and social issues.
  •     Identifies patient inaccuracies with self-reported medication use.
  •     Foster communication and reinforces trust between physician and patient.
If you are a physician requiring education on safety protocols and medication monitoring, please feel free to contact our laboratory for additional information.

AFTS Labs specializes in providing clinical oral fluid and urine drug testing for the substance abuse, pain management and forensic industries. With our reputation for accuracy and swift turnaround times, AFTS Labs is recognized as the premier facility for reliable results and clinical drug testing services. For more information please visit http://www.aftslabs.com or to become a customer, contact Cristen Cuomo at Ccuomo(at)aftslabs(dot)com or 888-214-8444.

Read the full story at http://www.prweb.com/releases/2012/7/prweb9656629.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related medicine news :

1. ArticlesOnTap.com Partners With OnlineLPNPrograms.net To Offer Consulting Services
2. GSW Telnet Server for Windows Partners with MobileDemand
3. American Academy of Family Physicians joins AmericanEHR Partners
4. The Biochar Company Partners with Hawaii Biochar Products
5. Candeo Partners with Catholic Church Organization to Release New Sexual Addiction Recovery Program
6. TeetheMe.com Partners with SwaddleDesigns
7. ACP-New York State Chapter partnership results in patient safety organization recognition
8. Cyber exercise partners help you go the distance
9. FDA clears test developed in partnership with VCU researcher
10. Global Cassava Partnership for the 21st Century (GCP21)
11. Partnership provides inclusive workout
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AFTS Labs Partners With Physicians To Complement NY's Mandated I-STOP Tracking System For Pain Pill Prescriptions: A Recipe For A Safer Community
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... Dec. 8, 2016  Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...
Breaking Medicine Technology: